David R. Simpson

2.5k total citations
14 papers, 1.1k citations indexed

About

David R. Simpson is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, David R. Simpson has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Genetics. Recurrent topics in David R. Simpson's work include Virus-based gene therapy research (1 paper), Medical Imaging Techniques and Applications (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). David R. Simpson is often cited by papers focused on Virus-based gene therapy research (1 paper), Medical Imaging Techniques and Applications (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). David R. Simpson collaborates with scholars based in United States, Canada and New Zealand. David R. Simpson's co-authors include Scott W. Lowe, Gregory J. Hannon, Ingrid Ibarra, Ross A. Dickins, Jack T. Zilfou, Michael T. Hemann, E. Alejandro Sweet‐Cordero, Alex G. Lee, Davide Ruggero and Dana M. Gwinn and has published in prestigious journals such as Nature Medicine, Nature Communications and Nature Genetics.

In The Last Decade

David R. Simpson

14 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David R. Simpson United States 9 571 225 163 158 153 14 1.1k
Mariam Anees Pakistan 17 373 0.7× 166 0.7× 108 0.7× 88 0.6× 204 1.3× 45 870
Jinxiang Fu China 16 644 1.1× 507 2.3× 46 0.3× 143 0.9× 75 0.5× 88 1.2k
Jing Du China 15 557 1.0× 323 1.4× 43 0.3× 220 1.4× 90 0.6× 48 1.1k
Juntao Jiang China 21 497 0.9× 351 1.6× 279 1.7× 256 1.6× 93 0.6× 63 1.3k
Juxiang Chen China 18 408 0.7× 320 1.4× 51 0.3× 240 1.5× 60 0.4× 48 1.0k
Min Ren China 16 276 0.5× 134 0.6× 73 0.4× 107 0.7× 108 0.7× 45 902
Seema Srivastava Australia 14 424 0.7× 154 0.7× 91 0.6× 116 0.7× 126 0.8× 25 913
Moira Clerici Italy 13 381 0.7× 105 0.5× 75 0.5× 94 0.6× 144 0.9× 17 918
Yaowu He Australia 26 935 1.6× 358 1.6× 67 0.4× 340 2.2× 153 1.0× 58 1.8k
M. Colombo Italy 22 489 0.9× 109 0.5× 134 0.8× 234 1.5× 288 1.9× 58 1.3k

Countries citing papers authored by David R. Simpson

Since Specialization
Citations

This map shows the geographic impact of David R. Simpson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Simpson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Simpson more than expected).

Fields of papers citing papers by David R. Simpson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Simpson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Simpson. The network helps show where David R. Simpson may publish in the future.

Co-authorship network of co-authors of David R. Simpson

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Simpson. A scholar is included among the top collaborators of David R. Simpson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Simpson. David R. Simpson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kostyrko, Kaja, Marta Román, Alex G. Lee, et al.. (2023). UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma. Nature Communications. 14(1). 3966–3966. 19 indexed citations
2.
Simpson, David R., Diana Murray, Evan Paull, et al.. (2020). Oncoprotein-specific molecular interaction maps (SigMaps) for cancer network analyses. Nature Biotechnology. 39(2). 215–224. 17 indexed citations
3.
Márquez, César, Kaja Kostyrko, Amanda Koehne, et al.. (2019). Antitumor activity of an engineered decoy receptor targeting CLCF1–CNTFR signaling in lung adenocarcinoma. Nature Medicine. 25(11). 1783–1795. 51 indexed citations
4.
Gwinn, Dana M., Alex G. Lee, Crystal S. Conn, et al.. (2018). Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase. Cancer Cell. 33(1). 91–107.e6. 178 indexed citations
5.
Tringale, Kathryn R., Roshan Karunamuni, Tanya T. Nguyen, et al.. (2017). Prospective Trial of Quantitative Neuroimaging Correlates of Verbal and Nonverbal Memory Decline. International Journal of Radiation Oncology*Biology*Physics. 99(2). S101–S101. 3 indexed citations
6.
7.
Ron, Chen, et al.. (2013). Abstract PR08: Identifying effectors of WT1 that regulate KRAS-induced senescence and chemoresistance in non-small cell lung cancer. Molecular Cancer Therapeutics. 12(5_Supplement). PR08–PR08. 1 indexed citations
8.
Tivis, Rick, et al.. (2012). CANCER DEATHS AND OCCUPATIONAL EXPOSURE IN A GROUP OF PLUTONIUM WORKERS. Health Physics. 102(4). 443–452. 2 indexed citations
9.
Simpson, David R., Min Yu, Siyuan Zheng, et al.. (2011). Epithelial Cell Organization Suppresses Myc Function by Attenuating Myc Expression. Cancer Research. 71(11). 3822–3830. 8 indexed citations
10.
Simpson, David R.. (2008). Biofilm processes in biologically active carbon water purification. Water Research. 42(12). 2839–2848. 320 indexed citations
11.
Dickins, Ross A., Michael T. Hemann, Jack T. Zilfou, et al.. (2005). Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nature Genetics. 37(11). 1289–1295. 419 indexed citations
12.
Simpson, David R., et al.. (2004). Effectiveness of multidisciplinary patient counselling in reducing cardiovascular disease risk factors through nonpharmacological intervention: results from the Healthy Heart Program.. PubMed. 20(2). 177–86. 10 indexed citations
13.
Simpson, David R.. (2003). T-Cell Depleting Antibodies. BioDrugs. 17(3). 147–154. 30 indexed citations
14.
Theodorakis, Michael C., et al.. (1983). External Scintigraphy in Monitoring the Behavior of Pharmaceutical Formulations In Vivo I: Technique for Acquiring High-Resolution Images of Tablets. Journal of Pharmaceutical Sciences. 72(2). 130–135. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariam Anees Breakdown of academic impact, for papers by Jinxiang Fu Breakdown of academic impact, for papers by Jing Du Breakdown of academic impact, for papers by Juntao Jiang Breakdown of academic impact, for papers by Juxiang Chen Breakdown of academic impact, for papers by Min Ren Breakdown of academic impact, for papers by Seema Srivastava Breakdown of academic impact, for papers by Moira Clerici Breakdown of academic impact, for papers by Yaowu He Breakdown of academic impact, for papers by M. Colombo
Rankless by CCL
2026